GREEN CROSS WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 13,890
-310 (-2.18%)
At close: Apr 28, 2026
GREEN CROSS WellBeing Market Cap
GREEN CROSS WellBeing has a market cap or net worth of 246.48 billion as of April 28, 2026. Its market cap has increased by 68.57% in one year.
Market Cap
246.48B
Enterprise Value
318.06B
Revenue
164.68B
Ranking
n/a
PE Ratio
28.57
Stock Price
13,890.00
Market Cap Chart
Since October 14, 2019, GREEN CROSS WellBeing's market cap has increased from 221.90B to 246.48B, an increase of 11.08%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 246.48B | 51.97% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 479.90B |
| HEM Pharma | 421.96B |
| DAE HWA Pharmaceutical | 265.38B |
| NOVAREX | 264.12B |
| High Tech Pharm | 211.60B |
| Vivozon Pharmaceutical | 192.83B |
| OPTUS Pharmaceutical | 165.53B |
| Organoidsciences | 154.44B |